Beam Therapeutics received the 2026 Life Sciences Award from Triangle Business Journal, with the honor formally presented at the company's North Carolina office by a representative from Senator ...
Beam Therapeutics has been awarded the Overall CGT Solution of the Year for its alpha-1 antitrypsin deficiency program, BEAM-302. This recognition comes from the esteemed BioTech Awards, ...